FLUAD TETRA

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, Spain, UK.

Active ingredients

The drug FLUAD TETRA contains a combination of these active pharmaceutical ingredients (APIs):

1	A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022 IVR-238)
	Read more about Influenza, inactivated, surface antigen
2	A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022, IVR-237)
	Read more about Influenza, inactivated, surface antigen
3	B/Austria/1359417/2021-like strain (B/Austria/1359417/2021 BVR-26)
	Read more about Influenza, inactivated, surface antigen
4	B/Phuket/3073/2013-like strain (B/Phuket/3073/2013 BVR‐1B)
	Read more about Influenza, inactivated, surface antigen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLUAD TETRA Suspension for injection in pre-filled syringe	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1819098, 1819100, 1819111, 1819122
ES	Centro de información online de medicamentos de la AEMPS	1201433001
FR	Base de données publique des médicaments	60094805
GB	Medicines & Healthcare Products Regulatory Agency	389723, 389734
IT	Agenzia del Farmaco	048797017, 048797029, 048797031, 048797043
LT	Valstybinė vaistų kontrolės tarnyba	1090319, 1090320, 1090321, 1090322
PL	Rejestru Produktów Leczniczych	100442002